Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K120303
    Manufacturer
    Date Cleared
    2012-06-05

    (125 days)

    Product Code
    Regulation Number
    876.4480
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    CYBERWAND DUAL ACTION ULTRASONIC LITHOTRIPSY SYSTEM

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The CyberWand Dual Action Ultrasonic Lithotripsy System is intended to be used for the fragmentation of urinary tract calculi in the kidney, ureter and bladder.

    Device Description

    The CyberWand Dual Action Ultrasonic Lithotripsy System includes a Generator, Transducer (2), Footswitch, Power Cord, Wrench, and Cleaning Stylet. The disposable probe set is sold separately either sterile or non-sterile. The Cybersonics CyberWand Dual Probe Ultrasonic Lithotripsy System is an electromechanical device capable of fragmenting and aspirating calculi. The hand piece consists of an ultrasonic transducer containing the piezoelectric elements, which are driven by a generator operating at 20400 - 22200 Hz. The resulting longitudinal waves are propagated along the ultrasonic dual probe to the target stone. The ultrasonic transducer probes are hollow, permitting simultaneous suction.

    AI/ML Overview

    Here's an analysis of the provided text regarding the acceptance criteria and supporting studies for the CyberWand Dual Action Ultrasonic Lithotripsy System:

    Summary of Device and Context:

    The CyberWand Dual Action Ultrasonic Lithotripsy System is an electromechanical device designed for the fragmentation and aspiration of urinary tract calculi (kidney, ureter, and bladder stones). This submission is an Abbreviated 510(k), indicating a reliance on substantial equivalence to previously cleared predicate devices.

    Acceptance Criteria and Reported Device Performance:

    Based on the provided text, the acceptance criteria are primarily focused on safety, performance standards compliance, and equivalence to predicate devices, rather than specific clinical efficacy metrics like sensitivity or specificity.

    Acceptance Criteria CategorySpecific CriteriaReported Device Performance (CyberWand Dual Action Ultrasonic Lithotripsy System)
    Substantial EquivalenceEquivalency in: Indications for Use, ultrasonic technology, operating principle, basic configuration, materials."Substantially equivalent with the predicate device, CyberWand Dual Probe Lithotripter (K052135)." Also compared to CyberWand Hollow Semi-Flexible Ureteral Probe Lithotripter (K102169). Stated similarities: "Same indications for use, Same ultrasonic technology, Same operating principle, Same basic configuration, Same materials."
    International Standards Compliance (Performance)Compliance with IEC 61847:1998 - Ultrasonics, Surgical Systems - Measurement and Declaration of the Basic Output Characteristics."Cybersonics prepared an evaluation report which provides a declaration of output characteristics."
    Verification and Validation (Device Performance)Performance tests for the Advanced Transducer, including pre-sterilization and post-sterilization performance: Drill Rate, Laser Vibrometer, Surface Temperature Profile, Interface and Compatibility, Steam Sterilization, and Endurance Durability."Verification and Validation studies for the Advanced Transducer were performed and documented in a formal report which included results for pre-sterilization and post-sterilization performance tests (Drill Rate Study, Laser Vibrometer Study, Surface Temperature Profile Study, Interface and Compatibility Study, Steam Sterilization and Endurance Durability Study)." (Specific numerical results are not provided in this summary, only that they were performed and documented).
    Electrical Safety Standards ComplianceCompliance with IEC 60601-1:2005 3rd Edition (Class I equipment with Type BF applied part)."The CyberWand Dual Action Ultrasonic Lithotripsy System is classified as Class I equipment with a Type BF applied part that complies with IEC 60601-1.2005 3rd Edition."
    Electromagnetic Compatibility (EMC)Compliance with: EN 60601-1-2:2007 (emission and immunity), IECES-003, Issue 4:2004, FCC Part 15, Subpart B, EN55011:2007 (emissions), EN61000-3-2:2006 (harmonic current emissions), EN61000-3-3:2008 (voltage changes, fluctuations, flicker)."The evaluation... illustrates that the unit meets the emission requirements of the EN 60601-1-2:2007... and with the requirements of IECES-003, Issue 4:2004, FCC Part 15, Subpart B and European Standard EN55011:2007... including Amendment A1:2010." "The evaluation... illustrates that the unit meets the immunity requirements of EN60601-1-2:2007..." "The evaluation... illustrates that the unit meets the requirements of EN61000-3-2:2006... and with EN61000-3-3:2008..."
    Software ValidationCompliance with FDA's "Moderate Level of Concern" recommendations for software contained in medical devices ("Guidance for the Content for Premarket Submissions for Software Contained in Medical Devices (5/29/98)")."Software validation for the cycle operation has been performed according to the FDA's Moderate Level of Concern recommendations..."
    Sterilization Validation (Steam - Advanced Transducer)Sterilization of Advanced Transducer to achieve an SAL minimum of 10^-6^ against ISO 17665-1:2006. Effective sterilization at 132C for a 2-minute Prevac half cycle. Thermocouple verification calibration passed. All controls satisfactory."Prevacuum steam sterilization technique has been qualified against the ISO 17665-:2006... The results of the biological indicators and inoculated device indicated no spore survivors for three consecutive half cycles... judged to be effectively sterilized at 132C for a 2 minute Prevac half cycle and zero minute dry time... considered adequate to achieve an SAL minimum of 10^-6^ at twice the stated exposure time. The thermocouples passed the verification calibration. All positive and negative controls were satisfactory."
    Sterilization Validation (Steam - Probes)Sterilization of CyberWand probes to achieve 10^-6^ sterility assurance level (SAL) using the overkill method, as defined in AAMI-TIR:2004. Effective sterilization at 132C for a 2-minute Prevac half cycle (double wrapped probes)."A steam sterilization study with the CyberWand probes was conducted to determine if exposure of the double wrapped probes would produce the required 10^-6^ sterility assurance level using the overkill method... The CyberWand probes, doubled wrapped, was judged to be effectively sterilized at 132C for a 2 minute Prevac half cycle and zero minute dry time."
    Sterilization Validation (ETO - Advanced Transducer)Sterilization of Advanced Transducer using 100% ethylene oxide at 55C for 50 minutes with 12-hour aeration, against ISO 10993-7:2008 (residuals) and achieving an SAL of 10^-6^ using biological indicator overkill method. Allowable limits for ETO, ECH, and EG."The Advanced Transducer was also validated in a 100% ethylene oxide sterilization cycle at 55C for 50 minutes sterilize with twelve (12) hour aeration against the ISO 10993-7:2008... The study demonstrated that ethylene oxide (ETO), and its common degradants ethylene chlorohydrin (ECH) and ethylene glycol (EG), are within the allowable limits. The Advanced Transducer also demonstrated a sterility assurance level (SAL) of 10^-6^ using the biological indicator... overkill method."
    Sterilization Validation (ETO - Sterile Probe Sets)Requalification of sterilization process for CyberWand Sterile Probe Sets to confirm 10^-6^ SAL, in accordance with ANSI/AAMI/ISO 11135-1:2007. Bioburden testing and EO residual testing to verify aeration hold time."A study was conducted to validate the sterilization process for the CyberWand Sterile Probe Sets to confirm that the sterility assurance level (SAL) of 10^-6^ is obtained. This requalification was performed by Ethox and done in accordance with ANSI/AAMI/ISO 11135-1:2007... This study also included bioburden testing and EO residual testing to verify the previously validated EO aeration hold time."

    Since this is an Abbreviated 510(k) submission for a device built on established technology with predicate devices, the "study that proves the device meets the acceptance criteria" primarily consists of:

    • Engineering bench testing and verification studies: These confirm that the new device adheres to specific design specifications, performance parameters (like drill rate, vibration, temperature profiles), compatibility, and durability, replicating or exceeding previous results.
    • Compliance with recognized national and international consensus standards: This is a key component of demonstrating safety and fundamental performance for such devices.
    • Validation of manufacturing processes: Especially sterilization and software.

    The document does not describe a clinical study comparing human readers with AI assistance, or any clinical performance metrics like sensitivity, specificity, or clinical outcomes (e.g., stone fragmentation rates in patients). This is typical for devices cleared via substantial equivalence where safety and basic performance are demonstrated through non-clinical means and equivalence to a device with a known safety and efficacy profile.

    Here's a breakdown of the other requested information based on the provided text:

    1. Sample size used for the test set and the data provenance:

      • Test Set Sample Size: Not applicable in the context of a typical clinical test set for AI performance. The "test sets" here refer to batches of devices/components used for engineering verification (e.g., advanced transducers, probes) and sterility validation (e.g., biological indicators, inoculated devices, double wrapped probes). Specific numerical sample sizes for these tests are not provided in the summary but are generally defined by the relevant standards and protocols.
      • Data Provenance: The studies are internal company verification and validation studies conducted by Cybersonics, and external validation performed by Ethox for sterilization. The data is prospective, generated specifically for this submission.
    2. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

      • Not applicable as there is no mention of a "ground truth" derived from expert consensus interpretation of medical images or clinical cases. The "ground truth" for the engineering and sterilization studies is established by the specifications in the standards themselves, physical measurements, and biological indicator results.
    3. Adjudication method (e.g. 2+1, 3+1, none) for the test set:

      • Not applicable, as no expert adjudication process is described.
    4. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

      • No, an MRMC comparative effectiveness study was not done. This device is a physical, invasive surgical tool (lithotripter), not an AI-powered diagnostic or interpretive device. Therefore, the concept of "human readers improve with AI assistance" is not relevant to this submission.
    5. If a standalone (i.e. algorithm only without human-in-the loop performance) was done:

      • Not applicable. This device is a physical instrument, not an algorithm. Its operation inherently involves a human surgeon.
    6. The type of ground truth used (expert concensus, pathology, outcomes data, etc):

      • Engineering/Performance Tests: The ground truth for these tests is defined by the technical specifications, design requirements, and performance parameters outlined in relevant international standards (e.g., IEC 61847) and internal company specifications. This involves objective physical measurements (e.g., drill rate, vibration frequency, temperature).
      • Sterilization Validation: The ground truth is the achievement of a specific Sterility Assurance Level (SAL, typically 10^-6^) as measured by biological indicators and validated against standards like ISO 17665-1, AAMI-TIR, ISO 10993-7, and ANSI/AAMI/ISO 11135-1. EO residuals are compared to allowable limits.
    7. The sample size for the training set:

      • Not applicable. This submission does not describe an AI model with a training set. The "training" mentioned refers to the training of sales representatives and users on the device's proper use.
    8. How the ground truth for the training set was established:

      • Not applicable. (See #8)
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1